Hepcdac Tablets

Description

Marketed        : Cipla

Indian Brand : Hepcdac Tablets
Active Ingredient(s) : Daclatasvir
Strength         :60mg
Dosage Form : Tablet
Package Size : 28 Tabs
Package Type: Plastic Bottle
Expiry              : 1 Year to 2 Years
Indication(s)    : Hepatitis C Virus (HCV) Infection
UPC / GTIN Barcode : No
Prescription Required : Yes

Hepcdac is consumed with another antiviral medication (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. These medications together helps in reducing the amount of hepatitis C virus in your body, which further helps your immune system fight the infection and may help your liver recover. Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.

In using this medication you may have to deal with side effects such as nausea, headache, weakness, fatigue, the breakdown of the redcell, diarrhea, drowsiness, dizziness and skin rash. If your reactions persist or become worse over time take the help of your healthcare provider right away.

The dosage of this medication should be determined by the doctor based on your age, overall medical history, and current condition. The usual dose in adults for treating chronic hepatitis C is 60 mg, taken orally one tablet daily for a period of 12 weeks.

You need to consult your doctor before taking HEPCDAC TABLETS during breastfeeding.
•         You should not drink alcohol.
•         If you experience any symptoms or illness you shall Consult your doctor.
•         Examine your liver function before  taking the drug.
•         If you are taking any other drugs along with HEPCDAC TABLETS, then you need to consult your doctor first.
The most common side effect of HEPCDAC TABLETS are as under:

• Nausea
• Vomiting
• Weight loss
• Dark-colored urine
• Diarrhea
• Insomnia
• A headache
• Fatigue